Minocycline Indications and Dosages

Indications

• The British Thoracic Society recommends minocycline for treatment of non-tuberculous mycobacterial pulmonary disease, though not licensed for this indication in the UK 1
• Minocycline is used as part of multi-drug regimens for non-tuberculous mycobacterial infections 1
• The American Academy of Dermatology indicates minocycline for moderate to severe inflammatory acne 2
• Minocycline is recommended as a second-line agent after doxycycline due to safety concerns, for the treatment of acne vulgaris 2
• The Infectious Diseases Society of America recommends minocycline as an effective treatment for methicillin-resistant Staphylococcus aureus skin and soft tissue infections 3, 4
• Minocycline is an alternative to vancomycin or linezolid for patients who cannot tolerate first-line agents for the treatment of skin and soft tissue infections 4

Dosage Recommendations

• The British Thoracic Society recommends a dosage of 100 mg twice daily (oral) for adults with non-tuberculous mycobacterial pulmonary disease 1
• The American Academy of Dermatology recommends a dosage of 50 mg 1-3 times daily for adults with acne vulgaris 5
• The Infectious Diseases Society of America recommends a dosage of 100 mg twice daily (oral) for adults with methicillin-resistant Staphylococcus aureus skin and soft tissue infections 3, 4

Contraindications

• The American Academy of Pediatrics and the British Thoracic Society contraindicate minocycline in children under 8 years of age due to risk of permanent tooth discoloration and enamel hypoplasia 1, 6, 5
• The American College of Obstetricians and Gynecologists contraindicates minocycline in pregnancy and breastfeeding 1, 5
• The British Thoracic Society contraindicates minocycline in patients with hypersensitivity to minocycline or other tetracyclines 1, 6
• The American College of Rheumatology contraindicates minocycline in patients with systemic lupus erythematosus (risk of exacerbation) 1

Precautions and Monitoring

• The British Thoracic Society recommends monitoring liver function, especially with prolonged use of minocycline 1
• The American Academy of Dermatology recommends complete blood count (CBC) weekly for first 2 months, then monthly if stable, for patients taking minocycline 1
• The National Kidney Foundation recommends using minocycline with caution in renal impairment; no dose adjustment required but monitor for adverse effects 1, 6
• The American Association for the Study of Liver Diseases recommends using minocycline with caution in hepatic impairment 1, 6
• The British Thoracic Society recommends avoiding direct exposure to sunlight or UV radiation due to photosensitivity risk 1

Adverse Effects

• The British Thoracic Society reports common adverse effects of minocycline, including gastrointestinal symptoms (nausea, vomiting, diarrhea, dysphagia) and dermatological symptoms (photosensitivity, rash) 1, 6
• The American Academy of Dermatology reports serious adverse effects of minocycline, including autoimmune disorders (drug-induced lupus, autoimmune hepatitis) and hypersensitivity reactions (DRESS syndrome) 2, 5
• The British Thoracic Society reports serious adverse effects of minocycline, including hepatotoxicity (hepatitis, jaundice, hepatic failure) and hematological effects (hemolytic anemia, thrombocytopenia, neutropenia) 1

Minocycline Dosing for Skin Infections

Recommended Dosing Regimens

• The standard maintenance dose of minocycline for adults is 100 mg twice daily, with a treatment duration of 7-14 days for skin and soft tissue infections 7
• For adults, an initial dose of 200 mg loading dose, then 100 mg every 12 hours is recommended 8
• For children ≥8 years and <45 kg, the recommended dose is 2 mg/kg/dose every 12 hours, while for those >45 kg, the adult dose of 100 mg twice daily is used 8

Clinical Applications for Skin Infections

• Minocycline is effective for outpatient management of skin and soft tissue infections, particularly those caused by methicillin-resistant Staphylococcus aureus (MRSA) 7, 8
• Minocycline is considered an alternative to other oral agents such as trimethoprim-sulfamethoxazole, doxycycline, and clindamycin for outpatient treatment 7

Special Considerations

• Inadequate duration of therapy, which should be at least 7 days, is a common pitfall in minocycline treatment for skin infections 8

Minocycline Dosing for Persistent Folliculitis

Standard Dosing Regimen

• For adults with persistent folliculitis, the American Academy of Dermatology recommends minocycline dosing at 100 mg orally twice daily, with a treatment duration of 7-14 days for bacterial folliculitis 9
• For pediatric patients (≥8 years) with body weight <45 kg, the dosing recommendation is 4 mg/kg loading dose, then 2 mg/kg every 12 hours, according to the Infectious Diseases Society of America 9
• For pediatric patients (≥8 years) with body weight ≥45 kg, the recommendation is to use adult dosing (100 mg twice daily), as suggested by the American Academy of Pediatrics 9

Clinical Context for Folliculitis

• Minocycline is effective for methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections, which commonly cause persistent folliculitis, as recommended by the Infectious Diseases Society of America 9

Minocycline Dosing Recommendations

Standard Adult Dosing

• The standard maintenance dose for adults with skin and soft tissue infections, including MRSA, is 100 mg orally twice daily, according to the Clinical Infectious Diseases guidelines 10, 11

Pediatric Dosing

• For children ≥8 years old, the recommended dose is a 4 mg/kg loading dose (maximum 200 mg), then 2 mg/kg every 12 hours (maximum 100 mg/dose), as per the Clinical Infectious Diseases guidelines 10
• Children ≥45 kg should use adult dosing of 100 mg twice daily, following the Clinical Infectious Diseases guidelines 10
• Children <45 kg should receive 2 mg/kg/dose every 12 hours, based on the Clinical Infectious Diseases guidelines 10

Minocycline Dosing Guidelines

Introduction to Minocycline Dosing

• The American Academy of Dermatology recommends that for acne vulgaris, minocycline dosing ranges from 50 mg 1-3 times daily up to 100 mg twice daily depending on severity, and notes that the drug should not be used unless benefits clearly outweigh risks in children under 8 years of age due to risk of permanent tooth discoloration and enamel hypoplasia 12

Pediatric Considerations

• For children <45 kg, the recommended dosing is 2 mg/kg/dose every 12 hours, and for children ≥45 kg, adult dosing of 100 mg twice daily is recommended, according to guidelines that suggest minocycline is contraindicated in children under 8 years of age 13

Drug Interactions and Safety

• The American Academy of Dermatology advises against administering minocycline with antacids, calcium, magnesium, or iron-containing preparations as these reduce absorption, and also recommends avoiding concurrent use with isotretinoin, methoxyflurane, and using caution with oral anticoagulants 12
• Minocycline is classified as Pregnancy Category D, and is contraindicated in pregnancy and breastfeeding, according to the American Academy of Dermatology 12

Minocycline Side Effects and Safety Considerations

Introduction to Minocycline Risks

• The American Academy of Dermatology recommends careful monitoring of minocycline use due to significant risks of common and severe adverse effects, particularly in adolescents and young adults, with the most concerning being autoimmune reactions, hyperpigmentation, and DRESS syndrome—risks that increase substantially with prolonged use beyond 3-4 months 14

Gastrointestinal and Central Nervous System Effects

• Nausea, vomiting, diarrhea, and dyspepsia are the most frequently reported adverse effects of minocycline, according to the American Academy of Dermatology 14
• Vestibular symptoms including dizziness, vertigo, and light-headedness are characteristic of minocycline and occur more frequently than with other tetracyclines, as reported by the American Academy of Dermatology 14

Dermatologic Effects and Drug Interactions

• Photosensitivity manifested by exaggerated sunburn reactions is a known side effect of minocycline, as stated by the American Academy of Dermatology 14
• Minocycline may reduce the effectiveness of hormonal contraceptives, and caution is advised when using oral anticoagulants due to potential interaction, according to the American Academy of Dermatology 14

Special Considerations for Adolescents and Young Adults

• Tooth discoloration and enamel hypoplasia can occur even in adolescents if permanent teeth are still developing, as warned by the American Academy of Dermatology 14
• Minocycline is contraindicated in pregnancy due to fetal harm, tooth discoloration, and skeletal development effects, and is also contraindicated in breastfeeding as it is excreted in breast milk, as stated by the American Academy of Dermatology 14